Company intelligence / Profile preview
Beijing Wante'er Biological Pharmaceutical
Beijing, Beijing, Chinaystwt.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Beijing Wante’er Biological Pharmaceutical develops therapeutics targeting neoplasms and bacterial infections. The company has at least one approved drug in China since April 2004 and ongoing discovery-stage research related to cancer therapy using bacteria-based nanodrugs. There are references to patents involving PD-1 but not clear evidence that these are clinical programs rather than intellectual property filings[1].
- Therapeutic areas
- Infectious DiseasesOncology
- Modalities
- Bacteria-based nanodrugSmall molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Beijing Wante'er Biological Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Wante'er Biological Pharmaceutical.